PS1353 PROGNOSTIC IMPACT OF T(8Q24)/CMYC IN MULTIPLE MYELOMA
T. Ya. Abramova(Universidad de Salamanca), Savchenko Vg(National Research Center for Hematology Russian Academy of Medical Sciences), Irina Galtseva(National Research Center for Preventive Medicine), Islam Nakastoev, Т. Н. Обухова(Ministry of Health of the Russian Federation), Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), A. Danilina, Е О Грибанова, С. В. Куликов(Universidad de Salamanca), L. A. Grebenyuk(Ministry of Health of the Russian Federation), M. V. Solovev(Ministry of Health of the Russian Federation), М. В. Фирсова(Ministry of Health of the Russian Federation), A. Grachev
Cited by 0
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59